Market Place
Sourcing Support
Rocket Pharmaceuticals to Attend Investor Conferences
28 Aug 2025 //
PHARMAWEB
Rocket Pharmaceuticals Q2 2025 Financial Results and Progress
07 Aug 2025 //
BUSINESSWIRE
Rocket Pharmaceuticals Investors Can Lead Securities Fraud
03 Jul 2025 //
PR NEWSWIRE
Robbins LLP Alerts Shareholders of Rocket Pharma Class Action
12 Jun 2025 //
PR NEWSWIRE
Rocket Pharma Reports Q1 2025 Financial Results & Progress
08 May 2025 //
BUSINESSWIRE
Citizen Health to Support PKP2 Cardiomyopathy Drug Development
07 May 2025 //
PR NEWSWIRE
Rocket Boosts Preparations For Launch With New Commercial Chief
08 Apr 2025 //
FIERCE PHARMA
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
27 Aug 2024 //
BUSINESSWIRE
Rocket Pharma LV Hematology Portfolio Data At ASGCT 2024
10 May 2024 //
BUSINESSWIRE
Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results
06 May 2024 //
BUSINESSWIRE
Rocket Announces Appointment of Aaron Ondrey as CFO and Additional Updates
26 Mar 2024 //
BUSINESSWIRE
Rocket Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
26 Feb 2024 //
BUSINESSWIRE
Rocket Pharmaceuticals Appoints R. Keith Woods to Board of Directors
12 Dec 2023 //
BUSINESSWIRE
Rocket Pharmaceuticals Reports Third Quarter 2023 Financial Results
06 Nov 2023 //
BUSINESSWIRE
Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral
19 Oct 2023 //
BUSINESSWIRE
Rocket to Participate in the Chardan 7th Annual Genetic Medicines Conference
26 Sep 2023 //
BUSINESSWIRE
Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock
13 Sep 2023 //
BUSINESSWIRE
Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12 Sep 2023 //
BUSINESSWIRE
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
06 Sep 2023 //
BUSINESSWIRE
Rocket Pharmaceuticals Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
BUSINESSWIRE
Rocket Lab Spacecraft Built for Varda Successfully Operating on Orbit
12 Jun 2023 //
BUSINESSWIRE
Rocket Presents Data from LV Hematology & AAV Cardiovascular Programs
19 May 2023 //
BUSINESSWIRE
Rocket Pharmaceuticals Reports 1Q 2023 FYR and Highlights Recent Progress
04 May 2023 //
BUSINESSWIRE
Rocket Pharma to Participate in the Bank of America Securities 2023 Conference
03 May 2023 //
BUSINESSWIRE
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
11 Apr 2023 //
BUSINESSWIRE
Rocket Pharma to Participate in the 43rd Annual Cowen Health Care Conference
01 Mar 2023 //
BUSINESSWIRE
Rocket Pharma Reports Fourth Quarter and Full Year 2022 Financial Results
27 Feb 2023 //
BUSINESSWIRE
Rocket Pharma to Present at the SVB Securities Global Biopharma Conference
09 Feb 2023 //
BUSINESSWIRE
Rocket Pharmaceuticals to Present at 41st Annual J.P. Morgan Conference
03 Jan 2023 //
BUSINESSWIRE
Rocket Pharma Provides Update on Anticipated Registration Path for RP-A501
22 Dec 2022 //
PRESS RELEASE
Rocket Pharmaceuticals Presents Positive Data from Fanconi Anemia at ASH
12 Dec 2022 //
BUSINESSWIRE
Rocket Pharmaceuticals Completes Acquisition of Renovacor
01 Dec 2022 //
BUSINESSWIRE
Rocket Pharma to Present at the 5th Annual Evercore ISI HealthCONx Conference
21 Nov 2022 //
BUSINESSWIRE
Rocket Announces Presentations Highlighting AAV and Lentiviral Gene Therapies
03 Nov 2022 //
BUSINESSWIRE
Rocket Pharma Reports Q3 2022 Financial Results and Highlights Recent Progress
03 Nov 2022 //
BUSINESSWIRE
Rocket PharmaAnnounces Presentations Highlighting Lentiviral Gene Therapies
12 Oct 2022 //
BUSINESSWIRE
Rocket Pharmaceuticals to Present at the 2022 Cell & Gene Meeting on the Mesa
10 Oct 2022 //
BUSINESSWIRE
Rocket Pharmaceuticals slides over 6% after hours on $100M stock offering
03 Oct 2022 //
SEEKINGALPHA
Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock
03 Oct 2022 //
BUSINESSWIRE
Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock
03 Oct 2022 //
BUSINESSWIRE
Rocket`s gene therapy data bring heart failure phase 2 closer
30 Sep 2022 //
FIERCEBIOTECH
Rocket Pharma to Present at Chardan 6th Annual Genetic Medicines Conference
27 Sep 2022 //
BUSINESSWIRE
Rocket Pharmaceuticals snaps up gene therapy startup Renovacor
21 Sep 2022 //
FIERCEBIOTECH
Rocket Fuels AAV Cardiac Portfolio with Renovacor Buy
20 Sep 2022 //
BIOSPACE
Rocket Pharma to Present Updated Data from PI Danon Disease Trial for RP-A501
16 Sep 2022 //
BUSINESSWIRE
Rocket to Present at Morgan Stanley 20th Annual Global Healthcare Conference
06 Sep 2022 //
BUSINESSWIRE
Rocket Pharmaceuticals Reports Second Quarter 2022 Financial Results
08 Aug 2022 //
BUSINESS WIRE
Rocket Pharma Appoints M. Pujols as CTO; Strengthens Manufacturing Capabilities
27 Jul 2022 //
BUSINESSWIRE
Rocket Pharmaceuticals to Present at William Blair Biotech Focus Conference
08 Jul 2022 //
BUSINESSWIRE
Touting 100% OS rate in pivotal rare disease trial, Rocket Pharma heads to FDA
21 May 2022 //
ENDPTS
Rocket Pharma Presents Data from Severe Leukocyte Adhesion Deficiency-I Program
19 May 2022 //
BUSINESSWIRE
Rocket Pharma Presents Positive Clinical Data from Various Programs at ASGCT
16 May 2022 //
BUSINESSWIRE
Rocket Pharmaceuticals to Present at UBS Global Healthcare Conference
11 May 2022 //
BUSINESSWIRE
Rocket Pharma Reports First Quarter 2022 Financial Results
05 May 2022 //
BUSINESSWIRE
Rocket Pharmaceuticals to Present at the Bank of America Securities 2022
27 Apr 2022 //
BUSINESSWIRE
Rocket Pharmaceuticals Appoints Fady Malik, M.D., Ph.D., to Board of Directors
14 Mar 2022 //
BUSINESSWIRE
Rocket Pharma Appoints J. Yeung as VP of Investor Relations, Corporate Finance
08 Mar 2022 //
BUSINESSWIRE
Rocket Pharmaceuticals Reports Q4 and Full Year 2021 Financial Results
24 Feb 2022 //
BUSINESSWIRE
Rocket Presents Positive Clinical Data from Lentiviral Gene Therapies
13 Dec 2021 //
BUSINESSWIRE
Rocket Pharmaceuticals Appoints Martin Wilson as General Counsel and Chief
08 Dec 2021 //
PRESS RELEASE
